Hospitalized Children Benefit from Antibiotic Stewardship Programs

Article

Hospitalized children go home sooner and are less likely to be readmitted when the hospital has an antibiotic stewardship program that’s dedicated to controlling antibiotic prescriptions and treatment, according to a study being presented at IDWeek 2014. The study is the first to show the benefits of such programs on children’s health.

Antibiotic stewardship programs are increasingly being used to manage how and when antibiotics are being prescribed in hospitals and other health care facilities across the country. Often led by epidemiologists or infectious diseases physicians, stewardship programs are designed to promote the appropriate use of antibiotics. Research shows up to half of antibiotics prescribed at hospitals are unnecessary or inappropriate, helping to foster the rise of antibiotic-resistant infections, which are difficult or impossible to treat.

“Studies have shown stewardship programs reduce antibiotic use and decrease the risk of antibiotic resistance, but this is the first to demonstrate that these programs actually reduce length of stay and readmission in children,” said Jason Newland, MD, lead author of the study and medical director of patient safety and systems reliability at Children’s Mercy Hospital-Kansas City, Mo. “These findings reinforce the health benefits of antibiotic stewardship programs for some of our most vulnerable patients. It’s clear that more hospitals should invest their resources in implementing such programs.”

Over the course of the five-year study, the antibiotic stewardship program at Children’s Mercy Hospital-Kansas City recommended that the prescribed antibiotic be discontinued or the dose or type of antibiotic be changed in 1,191 of 7,051 hospitalized children (17 percent) reviewed by the program. The child’s physician had the option of accepting or rejecting the recommendation.

When the program’s recommendations were followed, the length of stay was shorter, and 30-day admissions were reduced among children who did not have complex chronic care issues, such as cerebral palsy or congenital heart disease. The length of stay averaged 68 hours and there were no 30-day readmissions among children whose doctor followed the recommendation, while the length of stay averaged 82 hours and 3.5 percent were readmitted within 30 days among those whose doctor did not follow the recommendation.

The most common recommendation was to discontinue the antibiotic, because the antimicrobial stewardship program deemed it wasn’t necessary. Those who continued the antibiotic remained in the hospital so they could be monitored.

“Skeptics say stopping the antibiotics and sending the kids home sooner will lead to more children being readmitted, but we didn’t find that,” says Newland. “What we found was that kids were being taken off unnecessary antibiotics sooner – and in a safe manner.”

More than 2 million people are infected with antibiotic-resistant infections every year and 23,000 die, according to the Centers for Disease Control and Prevention (CDC).

IDWeek 2014 is the annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). With the theme “Advancing Science, Improving Care,” IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases, including HIV, across the lifespan. IDWeek 2014 takes place October 8-12 at the Pennsylvania Convention Center in Philadelphia.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content